Thinking of Buying SpaceX? Just Buy This Market-Thumping Stock Instead.

SpaceX is now roughly flat from its IPO after heavy AI investment post–xAI merger, targeting 10 GW of AI compute by end-2027. The article argues Nvidia is the higher-quality play: Nvidia reported 106% quarterly revenue growth and is trading at ~18x next-year EPS, with CEO Jensen Huang guiding to at least 70% growth next year. It notes SpaceX trades at ~64x sales and is forecast to be barely profitable this year ($0.09 EPS), making Nvidia comparatively less crash-prone even though SpaceX is building exclusively on Nvidia chips.

Analysis

The important read-through is not that one AI-linked name is “better” than another; it’s that frontier compute buyers are still consolidating around the incumbent platform, which should keep pricing power and software lock-in intact longer than the market assumes. That is constructive for NVDA’s multiple because the moat is increasingly ecosystem-based, not just unit-shipment-based. The incremental signal from a marquee customer publicly standardizing on Nvidia should also raise switching-cost expectations for other AI builders, which is bad for AMD/INTC narrative share even if it barely changes next-quarter revenue.

For SPCX, the market is likely overpricing the optionality while underpricing execution friction. A 10GW buildout is a capex, power, and supply-chain problem before it is a monetization story, so any schedule slip or financing detour would hit equity value quickly. In contrast, NVDA monetizes the same theme now; the gap between current cash flow and long-dated ambition is the core risk asymmetry.

The contrarian angle is that “exclusive on Nvidia” may be more signaling than economically material in the near term, so the immediate revenue uplift for NVDA could be modest. But signaling matters for valuation: it supports the idea that the highest-end AI customers still prefer the best-in-class stack, which can sustain gross margin and forward multiple expansion. The thesis breaks if hyperscaler capex decelerates sharply or if custom silicon/alternative architectures start winning frontier workloads in the next 2-3 quarters.

Key Decisions for Investors

• Long NVDA / short SPCX on any post-news strength; 1-3 month relative-value trade targeting multiple compression in the higher-duration name versus continued earnings momentum in NVDA. Falsify if NVDA guidance or data-center growth disappoints materially, or if SPCX secures committed financing that de-risks the 2027 compute ramp.
• Buy NVDA call spreads into the next earnings/capex commentary cycle; the setup is favorable because the market is still underweighting how much of AI demand is becoming platform-standardized. Risk/reward is best if implied vol remains elevated but not extreme.
• Short AMD vs long NVDA as a tactical pair if the market starts extrapolating this partnership into broader frontier-share loss for competitors. This is a sentiment/multiple trade more than a fundamental one; cover if AMD shows clear evidence of share gains in data center accelerators.
• Avoid chasing SPCX on this headline; wait for filings that quantify capex funding, power procurement, and customer concentration. If those disclosures show heavy dilution risk or delayed deployment, the equity could re-rate sharply lower over 6-18 months.
• Watch SMH as the clean sector hedge: if the market starts rotating from speculative AI names into cash-generative chips, the basket should outperform the broader AI-themed cohort. A break in NVDA leadership after the next guide would be the key signal that the “AI winner” trade is losing breadth.